Clinical benefit of cancer drugs approved in Switzerland 2010-2019
Clinical benefit of cancer drugs approved in Switzerland 2010-2019
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
It is unknown to what extent cancer drugs approved in Switzerland by the Swissmedic fulfil criteria of clinical benefit according to the European Society of Medical Oncology Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS), the American Society of Clinical Oncology Value Framework version 2 (ASCO-VF) and the Swiss OLUtool v2 (OLUtool).
Alternative Titles
Full title
Clinical benefit of cancer drugs approved in Switzerland 2010-2019
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2687693623
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2687693623
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0268545
